Search research articles
Contact Us
Filters
Showing results (451-460 of 454) with videos related to
Page
of 46
Sort By:
You have reached the last page of results.
This site can display upto 454 results.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
JCI Insight
|
October 5, 2021
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Angela M Minassian, Yrene Themistocleous, Sarah E Silk, et al.
Molecular Psychiatry
|
April 14, 2010
Genome-wide association study of bipolar I disorder in the Han Chinese population
M T M Lee, C H Chen, C S Lee, et al.
Lancet (London, England)
|
November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Page
of 46
Search research articles
Search
Showing results (451-460 of 454) with videos related to
Sort By:
Page
of 46
You have reached the last page of results.
This site can display upto 454 results.
The Lancet. Infectious Diseases
|
June 16, 2024
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E Silk, Wilmina F Kalinga, Jo Salkeld, et al.
JCI Insight
|
October 5, 2021
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Angela M Minassian, Yrene Themistocleous, Sarah E Silk, et al.
Molecular Psychiatry
|
April 14, 2010
Genome-wide association study of bipolar I disorder in the Han Chinese population
M T M Lee, C H Chen, C S Lee, et al.
Lancet (London, England)
|
November 22, 2020
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, et al.
Page
of 46